Pediatric low-grade glioma

3 papers study it1 more mentions it

Cells1

Trial sponsors

Day One Biopharmaceuticals
Company1 trialPhase 3418 people
St. Justine's Hospital
1 trialPhase 1/250 people

Latest

Signal Transduction and Targeted TherapyJun 24

Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models

Experiments in human cellsMAPK/ERK signaling

Neurochemistry InternationalOct 21

Ras, RhoA, and vascular pharmacology in neurodevelopment and aging

ReviewMechanisms

CellsJul 26

Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical Implications

ReviewCellular senescence

Child's Nervous SystemMay 25

MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models

ReviewMAPK/ERK signaling